Literature DB >> 21277386

Synthesis of enantiopure 2-carba-cyclic phosphatidic acid and effects of its chirality on biological functions.

Emi Nozaki1, Mari Gotoh, Harumi Hotta, Shuwa Hanazawa, Susumu Kobayashi, Kimiko Murakami-Murofushi.   

Abstract

Cyclic phosphatidic acid (cPA) is a naturally occurring phospholipid mediator, which has a quite unique cyclic phosphate ring at sn-2 and sn-3 positions of the glycerol backbone. We have designed and chemically synthesized several metabolically stabilized derivatives of cPA. 2-Carba-cPA (2ccPA) is one of the synthesized compounds in which the phosphate oxygen was replaced with a methylene group at the sn-2 position, and it showed much more potent biological activities than natural cPA. Here, we developed a new method of 2ccPA enantiomeric synthesis. And we examined the effects of 2ccPA enantiomers on autotaxin (ATX) activity, cancer cell invasion and nociceptive reflex. As well as racemic-2ccPA, both enantiomers showed inhibitory effects on ATX activity, cancer cell invasion and nociceptive reflex. As their effects were not significantly different from each other, the chirality of 2ccPA may not be critical for these biological functions of 2ccPA.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21277386     DOI: 10.1016/j.bbalip.2011.01.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  Regulation of autotaxin expression and secretion by lysophosphatidate and sphingosine 1-phosphate.

Authors:  Matthew G K Benesch; Yuan Y Zhao; Jonathan M Curtis; Todd P W McMullen; David N Brindley
Journal:  J Lipid Res       Date:  2015-04-20       Impact factor: 5.922

2.  Cyclic phosphatidic acid relieves osteoarthritis symptoms.

Authors:  Mari Gotoh; Aya Nagano; Ryoko Tsukahara; Hiromu Murofushi; Toshiro Morohoshi; Kazuyuki Otsuka; Kimiko Murakami-Murofushi
Journal:  Mol Pain       Date:  2014-08-14       Impact factor: 3.395

3.  Protective and therapeutic role of 2-carba-cyclic phosphatidic acid in demyelinating disease.

Authors:  Shinji Yamamoto; Kota Yamashina; Masaki Ishikawa; Mari Gotoh; Sosuke Yagishita; Kensuke Iwasa; Kei Maruyama; Kimiko Murakami-Murofushi; Keisuke Yoshikawa
Journal:  J Neuroinflammation       Date:  2017-07-21       Impact factor: 8.322

4.  Protection of neuroblastoma Neuro2A cells from hypoxia-induced apoptosis by cyclic phosphatidic acid (cPA).

Authors:  Mari Gotoh; Katsura Sano-Maeda; Hiromu Murofushi; Kimiko Murakami-Murofushi
Journal:  PLoS One       Date:  2012-12-12       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.